Member login

Forgot Password?

By using the members area you have already agreed to share your personal information with the BGMA/BBA so that you can access the members materials. We will store your details only as long as you are a member. Your personal information will not be shared any affiliated companies or third parties. For more information about our Privacy Policy, click here.

Return to login
Back to News index

Statement of intent for UK life sciences


UK life sciences industry commitment to fighting COVID-19 and supporting NHS patients

As part of the health community, the life sciences sector in the UK wants to play as big a role as possible in tackling COVD-19 – both in the search for effective diagnostics and treatments and by supporting patients, the NHS and Government across the UK. 
Our companies have the experience, knowledge and facilities to provide support across healthcare if they work together during this crisis. We are focussed on three areas: 

1. Delivering medicines and health technology to fight COVID-19 

  • Prioritise research and development of COVID-19 related diagnostics, treatments, health technologies and vaccines.
  • Facilitate input and intelligence sharing from companies to support patient testing and therapeutics.
  • Identify and support companies to facilitate testing for COVID-19. 

2. Prioritising the supply of diagnostics, medicines and health technologies for NHS patients 

  • We are prioritising getting medicines and health technologies to NHS patients, working to mitigate any impact that global supply chain, manufacturing and transport disruption may have on the availability of medicines and health technologies, including for clinical study and research activities. 

3.  Supporting NHS service delivery 

  • Identify and support the opportunities for thousands of highly skilled people working in life science - including doctors, nurses and pharmacists and non-clinical staff – to volunteer to help where most needed
  • Supporting the NHS to improve capacity for COVID-19 testing and diagnostics.

Download a PDF copy of this statement here.